Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $16,240 | 1,037 | 94.5% |
| Travel and Lodging | $690.16 | 3 | 4.0% |
| Consulting Fee | $250.00 | 1 | 1.5% |
| Education | $5.12 | 2 | 0.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Abbott Laboratories | $9,997 | 649 | $0 (2024) |
| SI-BONE, INC. | $1,099 | 17 | $0 (2024) |
| Vertos Medical, Inc. | $693.97 | 10 | $0 (2024) |
| Medtronic, Inc. | $525.45 | 14 | $0 (2024) |
| Egalet US Inc | $504.41 | 72 | $0 (2018) |
| Zyla Life Sciences, Inc. | $468.74 | 62 | $0 (2020) |
| Akrimax Pharmaceuticals, LLC | $390.56 | 31 | $0 (2017) |
| Boston Scientific Corporation | $339.10 | 9 | $0 (2024) |
| Collegium Pharmaceutical, Inc. | $276.85 | 19 | $0 (2024) |
| ABBVIE INC. | $263.21 | 17 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $4,343 | 139 | Abbott Laboratories ($1,611) |
| 2023 | $2,165 | 130 | Abbott Laboratories ($1,760) |
| 2022 | $1,999 | 142 | Abbott Laboratories ($1,767) |
| 2021 | $1,359 | 86 | Abbott Laboratories ($1,016) |
| 2020 | $1,405 | 113 | Abbott Laboratories ($865.62) |
| 2019 | $1,556 | 123 | Abbott Laboratories ($652.51) |
| 2018 | $2,054 | 142 | Abbott Laboratories ($1,350) |
| 2017 | $2,307 | 168 | Abbott Laboratories ($975.36) |
All Payment Transactions
1,043 individual payment records from CMS Open Payments — Page 1 of 42
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/30/2024 | Abbott Laboratories | PROCLAIM (Device) | Food and Beverage | In-kind items and services | $24.38 | General |
| Category: Neuromodulation | ||||||
| 12/27/2024 | Abbott Laboratories | ETERNA (Device) | Food and Beverage | In-kind items and services | $29.49 | General |
| Category: Neuromodulation | ||||||
| 12/27/2024 | Abbott Laboratories | ETERNA (Device) | Food and Beverage | In-kind items and services | $24.87 | General |
| Category: Neuromodulation | ||||||
| 12/27/2024 | Abbott Laboratories | ETERNA (Device) | Food and Beverage | In-kind items and services | $8.36 | General |
| Category: Neuromodulation | ||||||
| 12/27/2024 | Abbott Laboratories | ETERNA (Device) | Food and Beverage | In-kind items and services | $7.53 | General |
| Category: Neuromodulation | ||||||
| 12/19/2024 | Abbott Laboratories | ETERNA (Device) | Food and Beverage | In-kind items and services | $18.30 | General |
| Category: Neuromodulation | ||||||
| 12/16/2024 | Medtronic, Inc. | SYNCHROMEDII (Device) | Food and Beverage | In-kind items and services | $169.67 | General |
| Category: Drug Infusion Systems | ||||||
| 12/16/2024 | Abbott Laboratories | PROCLAIM (Device) | Food and Beverage | In-kind items and services | $50.66 | General |
| Category: Neuromodulation | ||||||
| 12/16/2024 | Abbott Laboratories | PROCLAIM (Device) | Food and Beverage | In-kind items and services | $14.11 | General |
| Category: Neuromodulation | ||||||
| 12/16/2024 | Abbott Laboratories | PROCLAIM (Device) | Food and Beverage | In-kind items and services | $7.68 | General |
| Category: Neuromodulation | ||||||
| 12/12/2024 | Abbott Laboratories | ETERNA (Device) | Food and Beverage | In-kind items and services | $19.02 | General |
| Category: Neuromodulation | ||||||
| 12/09/2024 | SI-BONE, INC. | — | Food and Beverage | Cash or cash equivalent | $47.13 | General |
| 11/29/2024 | Abbott Laboratories | PROCLAIM (Device) | Food and Beverage | In-kind items and services | $50.82 | General |
| Category: Neuromodulation | ||||||
| 10/31/2024 | Boston Scientific Corporation | — | Food and Beverage | In-kind items and services | $17.59 | General |
| Category: General - Pain Management_NMD | ||||||
| 10/31/2024 | Medtronic, Inc. | VANTA ADAPTIVESTIM (Device) | Food and Beverage | In-kind items and services | $8.76 | General |
| Category: Spinal Cord Neurostimulation | ||||||
| 10/30/2024 | Lilly USA, LLC | EMGALITY (Drug) | Food and Beverage | In-kind items and services | $15.54 | General |
| Category: Neuroscience | ||||||
| 10/26/2024 | Averitas Pharma Inc. | QUTENZA (Drug) | Food and Beverage | In-kind items and services | $24.59 | General |
| Category: PAIN MANAGEMENT | ||||||
| 10/24/2024 | SI-BONE, INC. | — | Food and Beverage | Cash or cash equivalent | $22.03 | General |
| 10/24/2024 | Abbott Laboratories | PROCLAIM (Device) | Food and Beverage | In-kind items and services | $8.89 | General |
| Category: Neuromodulation | ||||||
| 10/24/2024 | Abbott Laboratories | PROCLAIM (Device) | Food and Beverage | In-kind items and services | $7.40 | General |
| Category: Neuromodulation | ||||||
| 10/24/2024 | Abbott Laboratories | PROCLAIM (Device) | Food and Beverage | In-kind items and services | $5.06 | General |
| Category: Neuromodulation | ||||||
| 10/21/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $20.14 | General |
| Category: NEUROSCIENCE | ||||||
| 10/10/2024 | Medtronic, Inc. | VANTA ADAPTIVESTIM (Device) | Food and Beverage | In-kind items and services | $10.02 | General |
| Category: Spinal Cord Neurostimulation | ||||||
| 10/09/2024 | Averitas Pharma Inc. | QUTENZA (Drug) | Food and Beverage | In-kind items and services | $19.45 | General |
| Category: PAIN MANAGEMENT | ||||||
| 10/07/2024 | Abbott Laboratories | PROCLAIM (Device) | Food and Beverage | In-kind items and services | $49.36 | General |
| Category: Neuromodulation | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 44 | 3,225 | 16,333 | $2.0M | $526,396 |
| 2022 | 39 | 3,024 | 11,462 | $1.7M | $486,144 |
| 2021 | 35 | 3,078 | 12,757 | $1.4M | $451,936 |
| 2020 | 39 | 2,672 | 11,681 | $2.0M | $548,350 |
All Medicare Procedures & Services
160 procedure records from CMS Medicare Utilization — Page 1 of 7
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 22514 | Treatment of broken lower spine bone with placement of stabilizing device | Office | 2023 | 17 | 19 | $429,774 | $91,778 | 21.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 319 | 821 | $120,063 | $53,847 | 44.8% |
| 22515 | Treatment of broken spine bone with stabilizing device, each additional segment | Office | 2023 | 13 | 16 | $219,674 | $39,942 | 18.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 225 | 370 | $80,268 | $37,254 | 46.4% |
| 64483 | Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, single level | Office | 2023 | 126 | 163 | $127,612 | $37,070 | 29.0% |
| 64636 | Destruction of lower or sacral spinal facet joint nerves using imaging guidance, each additional facet joint | Office | 2023 | 47 | 161 | $84,399 | $32,383 | 38.4% |
| 64635 | Destruction of lower or sacral spinal facet joint nerves using imaging guidance, single facet joint | Office | 2023 | 50 | 86 | $109,064 | $30,495 | 28.0% |
| 0275T | Removal of bone from lower spine for decompression of nerve tissue using imaging guidance, accessed through the skin | Facility | 2023 | 26 | 28 | $77,200 | $20,266 | 26.3% |
| J3304 | Injection, triamcinolone acetonide, preservative-free, extended-release, microsphere formulation, 1 mg | Office | 2023 | 19 | 1,248 | $66,681 | $16,590 | 24.9% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 133 | 133 | $43,999 | $16,378 | 37.2% |
| 77002 | Fluoroscopic guidance for needle placement | Office | 2023 | 75 | 150 | $35,816 | $13,526 | 37.8% |
| 64493 | Injection of lower or sacral spine facet joint using imaging guidance, single level | Office | 2023 | 33 | 59 | $44,675 | $11,475 | 25.7% |
| 62323 | Injection of substance into lower spine canal using imaging guidance | Office | 2023 | 43 | 54 | $40,291 | $10,991 | 27.3% |
| 64634 | Destruction of upper or middle spinal facet joint nerves using imaging guidance, each additional facet joint | Office | 2023 | 17 | 46 | $26,348 | $9,833 | 37.3% |
| 99152 | Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | Office | 2023 | 134 | 236 | $47,526 | $9,734 | 20.5% |
| 27096 | Injection of anesthetic or steroid into joint between lower spine and hip bone using imaging guidance | Office | 2023 | 44 | 61 | $35,927 | $8,893 | 24.8% |
| 62321 | Injection of substance into middle or upper spine canal using imaging guidance | Office | 2023 | 32 | 41 | $31,165 | $8,686 | 27.9% |
| 64633 | Destruction of upper or middle spinal facet joint nerves using imaging guidance, single facet joint | Office | 2023 | 17 | 24 | $30,696 | $8,482 | 27.6% |
| 64484 | Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, each additional level | Office | 2023 | 71 | 88 | $23,507 | $8,058 | 34.3% |
| 20610 | Aspiration and/or injection of fluid from large joint | Office | 2023 | 66 | 128 | $26,891 | $7,300 | 27.1% |
| 72100 | X-ray of lower and sacral spine, 2-3 views | Office | 2023 | 163 | 220 | $19,793 | $7,280 | 36.8% |
| 63650 | Insertion of spinal neurostimulator electrode array through skin | Facility | 2023 | 13 | 26 | $106,422 | $6,392 | 6.0% |
| 64494 | Injection of lower or sacral spine facet joint using imaging guidance, second level | Office | 2023 | 30 | 54 | $20,444 | $5,633 | 27.6% |
| 64490 | Injection of upper or middle spine facet joint using imaging guidance, single level | Office | 2023 | 17 | 30 | $20,988 | $5,461 | 26.0% |
| 72020 | X-ray of spine, 1 view | Office | 2023 | 77 | 200 | $11,190 | $4,078 | 36.4% |
About Dr. Christopher Vije, MD
Dr. Christopher Vije, MD is a Anesthesiology healthcare provider based in Austin, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 12/14/2006. The National Provider Identifier (NPI) number assigned to this provider is 1316009525.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Christopher Vije, MD has received a total of $17,186 in payments from pharmaceutical and medical device companies, with $4,343 received in 2024. These payments were reported across 1,043 transactions from 40 companies. The most common payment nature is "Food and Beverage" ($16,240).
As a Medicare-enrolled provider, Vije has provided services to 11,999 Medicare beneficiaries, totaling 52,233 services with total Medicare billing of $2.0M. Data is available for 4 years (2020–2023), covering 160 distinct procedure/service records.
Practice Information
- Specialty Anesthesiology
- Other Specialties Pain Medicine, Pain Medicine
- Location Austin, TX
- Active Since 12/14/2006
- Last Updated 03/14/2022
- Taxonomy Code 207L00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1316009525
Products in Payments
- PROCLAIM (Device) $4,765
- Proclaim Family of SCS IPGs (Device) $2,035
- Proclaim IPG (Device) $1,016
- SPRIX (Drug) $906.30
- IFUSE IMPLANT SYSTEM (Device) $716.94
- mild Device Kit (Device) $693.97
- SCS IPGs (Device) $400.99
- Primlev (Drug) $390.56
- ETERNA (Device) $371.99
- SYNCHROMEDII (Device) $351.34
- Axium INS DRG IPG (Device) $290.00
- SCS leads (Device) $267.49
- DRG IPGs (Device) $264.79
- DRG leads (Device) $250.02
- Zilretta (Drug) $236.82
- Movantik (Drug) $229.62
- Intracept (Device) $199.83
- Octrode SCS Leads (Device) $162.39
- Horizant (Drug) $153.69
- Senza Spinal Cord Stimulation System (Device) $128.01
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Anesthesiology Doctors in Austin
Iden Cowan, M.d, M.D
Anesthesiology — Payments: $290,110
Ryan Casey, Md, MD
Anesthesiology — Payments: $287,064
Daniel Berson, D.o, D.O
Anesthesiology — Payments: $236,033
Dr. David Nelson, Md, MD
Anesthesiology — Payments: $127,712
Clement Yeh, Md, MD
Anesthesiology — Payments: $68,773
Dr. John Schlitt, Md, MD
Anesthesiology — Payments: $38,553